Cargando…

Impact of Age at Diagnosis on Cardiotoxicity in High-Grade Osteosarcoma and Ewing Sarcoma Patients

BACKGROUND: Osteosarcoma and Ewing sarcoma patients face a significant risk of cardiotoxicity as defined by left ventricular dysfunction and heart failure (HF). OBJECTIVES: This study sought to evaluate the association between age at sarcoma diagnosis and incident HF. METHODS: A retrospective cohort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heemelaar, Julius C., Speetjens, Frank M., al Jaff, Ahmed A.M., Evenhuis, Richard E., Polomski, Elissa A.S., Mertens, Bart J.A., Jukema, J. Wouter, Gelderblom, Hans, van de Sande, Michiel A.J., Antoni, M. Louisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982211/ https://www.ncbi.nlm.nih.gov/pubmed/36875898 http://dx.doi.org/10.1016/j.jaccao.2022.11.016

Ejemplares similares

Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma
por: Heemelaar, Julius C., et al.
Publicado: (2022)

Original Research: Long-Term Prognosis After ST-Elevation Myocardial Infarction in Patients with a Prior Cancer Diagnosis
por: Heemelaar, Julius C., et al.
Publicado: (2021)

Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational study
por: Heemelaar, Julius C., et al.
Publicado: (2023)

Plaque Rupture in a Hodgkin Lymphoma Survivor without Cardiovascular Risk Factors 20 Years after Thoracic Radiotherapy: A Case Report
por: Polomski, Elissa A. S., et al.
Publicado: (2023)

Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors
por: Polomski, Elissa A. S., et al.
Publicado: (2022)

Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
por: Verschoor, Arie Jan, et al.
Publicado: (2019)

Survival Analysis of 3 Different Age Groups and Prognostic Factors among 402 Patients with Skeletal High-Grade Osteosarcoma. Real World Data from a Single Tertiary Sarcoma Center
por: Evenhuis, Richard E., et al.
Publicado: (2021)

(18)F-FDG PET-CT versus MRI for detection of skeletal metastasis in Ewing sarcoma
por: Bosma, S. E., et al.
Publicado: (2019)

Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery
por: Bosma, S. E., et al.
Publicado: (2019)

Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trial
por: Hazewinkel, Audinga-Dea, et al.
Publicado: (2022)

Introducing Fluorescence-Guided Surgery for Pediatric Ewing, Osteo-, and Rhabdomyosarcomas: A Literature Review
por: Rijs, Zeger, et al.
Publicado: (2021)

Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017)

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
por: van Maldegem, Annemiek M, et al.
Publicado: (2012)

Elevated resting heart rate is a marker of subclinical left ventricular dysfunction in hodgkin lymphoma survivors
por: Heemelaar, Julius C., et al.
Publicado: (2021)

Stereotactic Body Radiotherapy for Metastatic and Recurrent Ewing Sarcoma and Osteosarcoma
por: Brown, Lindsay C., et al.
Publicado: (2014)

Abnormalities of the FHIT Transcripts in Osteosarcoma and Ewing Sarcoma
por: Hinohara, Shin‐ichi, et al.
Publicado: (1998)

Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor
por: Knowles, Helen J, et al.
Publicado: (2010)

Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing’s sarcoma
por: Dai, Xing, et al.
Publicado: (2011)

Radiation-induced osteosarcoma following treatment of Ewing's sarcoma
por: Kristenson, Scott, et al.
Publicado: (2019)

Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma
por: Hou, Yulin, et al.
Publicado: (2023)

Treatment Strategies for Metastatic Soft Tissue Sarcomas
por: Wiltink, Lisette M., et al.
Publicado: (2021)

Systemic Metal Ion Concentrations in Patients With Hip and Knee Megaprostheses: A Prospective Cohort Study
por: de Smidt, Kiki Q., et al.
Publicado: (2022)

Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases
por: Mastboom, Monique J. L., et al.
Publicado: (2017)

Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: the Childhood Cancer Survivor Study
por: Nagarajan, R, et al.
Publicado: (2004)

MAPK/ERK Signaling in Osteosarcomas, Ewing Sarcomas and Chondrosarcomas: Therapeutic Implications and Future Directions
por: Chandhanayingyong, Chandhanarat, et al.
Publicado: (2012)

The impact of sarcopenia and sarcopenic obesity on survival in children with Ewing sarcoma and osteosarcoma
por: Buğdaycı, Onur, et al.
Publicado: (2023)

Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma
por: Evdokimova, Valentina, et al.
Publicado: (2022)

Osteosarcoma: Evolution of Treatment Paradigms
por: Jaffe, Norman, et al.
Publicado: (2013)

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
por: Fleuren, Emmy D. G., et al.
Publicado: (2023)

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
por: de Groot, Stefanie, et al.
Publicado: (2020)

Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis
por: Martin, Enrico, et al.
Publicado: (2018)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
por: Serra, Massimo, et al.
Publicado: (2021)

Doxorubicin induced neuro- and cardiotoxicities in experimental rats: Protection against oxidative damage by Theobroma cacao Stem bark()
por: Kosoko, A.M., et al.
Publicado: (2017)

Osteosarcoma: Lessons Learned and Future Avenues
por: Puri, Ajay, et al.
Publicado: (2013)

Assessment of Risk of Bias in Osteosarcoma and Ewing’s Sarcoma Randomized Controlled Trials: A Systematic Review
por: Koucheki, Robert, et al.
Publicado: (2021)

Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma
por: Sági, Judit C., et al.
Publicado: (2018)

What Do We Know about Survival in Skeletally Premature Children Aged 0 to 10 Years with Ewing Sarcoma? A Multicenter 10-Year Follow-Up Study in 60 Patients
por: Bosma, Sarah E., et al.
Publicado: (2022)

Zoledronate‐Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma
por: Lundberg, A.P., et al.
Publicado: (2016)

Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983)

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group
por: Kopp, Lisa M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p56fp8fmpauiijubrsvq8446j6